HOXB13 and prostate carcinoma: Moreover, HOXB13 was shown to preferentially bind a low-risk prostate cancer susceptibility allele located in an AR and FOXA1 binding site (i.e. rs339331), thereby enhancing RFX6 expression and promoting metastasis18.